Persistence on Disease Modifying Anti-Rheumatic Drugs Among Taiwan Established Rheumatoid Arthritis Patients

被引：0
|
作者：
Liu, Yi-Han [1 ]
Lin, Tzu-Chieh [1 ,2 ]
Yang, Yea-Huei Kao [1 ,2 ]
Chang, Hui-Jen [3 ]
机构：
[1] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ Hosp, Dept Pharm Serv, Tainan 70428, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
134
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [1] RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    KIRWAN, JR
    CURREY, HLF
    [J]. CLINICS IN RHEUMATIC DISEASES, 1983, 9 (03): : 581 - 599
  • [2] Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    Garrood, T
    Scott, DL
    [J]. BIODRUGS, 2001, 15 (08) : 543 - 561
  • [3] Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis
    Toby Garrood
    David L. Scott
    [J]. BioDrugs, 2001, 15 : 543 - 561
  • [4] Treatment Patterns of Disease-Modifying Anti-Rheumatic Drugs by Serostatus Among Patients with Rheumatoid Arthritis
    Jin, Yinzhu
    Liu, Jun
    Desai, Rishi
    Kim, Seoyoung
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3476 - 3479
  • [5] SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS ON THE TREATMENT WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, E.
    Ito, S.
    Kurosawa, Y.
    Taniguchi, S.
    Kobayashi, D.
    Abe, A.
    Otani, H.
    Nakazono, K.
    Murasawa, A.
    Narita, I.
    Ishikawa, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 985 - 985
  • [6] ADHERENCE TO BIOLOGIC AND CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mishra, P.
    [J]. VALUE IN HEALTH, 2018, 21 : S198 - S198
  • [7] Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Agarwal, S.
    Zaman, T.
    Handa, R.
    [J]. SINGAPORE MEDICAL JOURNAL, 2009, 50 (07) : 686 - 692
  • [8] ADHERENCE AND PERSISTENCE TO DISEASE MODIFYING ANTI RHEUMATIC DRUGS IN COLOMBIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Pertuz-Charris, N.
    Ochoa-Jaramillo, F. L.
    Gil-Calderon, D.
    Alzate-Vinasco, M. A.
    Velez-Marin, V.
    Hernandez-Parra, D.
    Pineda-Tamayo, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 326 - 326
  • [9] The economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patients
    Shahabi, Ahva
    Shafrin, Jason
    Zhao, Lauren
    Green, Sarah
    Curtice, Tammy
    Marshall, Alexander
    Paul, Damemarie
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (04) : 350 - 358
  • [10] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
12345